LP-005 Injection

BIOLOGICAL4 trials

Sponsors

Longbio Pharma, Longbio Pharma (Suzhou) Co., Ltd.

Conditions

Complement-mediated Renal DiseasesPNH - Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal HemoglobinuriaPeriodontitis

Phase 2

Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in PNH Patients.

Active, not recruitingNCT07212426

Longbio PharmaPNH - Paroxysmal Nocturnal Hemoglobinuria

Start: 2024-11-14End: 2028-03-31Updated: 2026-01-16

Efficacy, Safety, and Pharmacokinetics of LP-005 Injection in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Not yet recruitingNCT07266155

Longbio PharmaParoxysmal Nocturnal Hemoglobinuria

Start: 2025-12-05End: 2028-05-01Target: 30Updated: 2025-12-05

Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease

Not yet recruitingNCT07363265

Longbio PharmaComplement-mediated Renal Diseases

Start: 2026-02-02End: 2029-05-02Target: 46Updated: 2026-01-23

Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis

Not yet recruitingNCT07603713

Longbio Pharma (Suzhou) Co., Ltd.Periodontitis

Start: 2026-05-01End: 2027-03-23Target: 100Updated: 2026-05-22